Business Context and Reporting Period
This Form 8-K filing by Nephros, Inc. (Delaware) reports on the 2019 Annual Meeting of Stockholders held on May 22, 2019. The company is headquartered in South Orange, New Jersey.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes
No material financial changes or operational updates were disclosed in this filing. The primary events were the election of directors and the ratification of the independent auditor.
Guidance, Outlook, and Management Commentary
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies. It strictly details the outcomes of shareholder votes.
Key Facts for Investor Verification
- Director Election: Stockholders elected Paul A. Mieyal and Malcolm Persen to the Board of Directors for three-year terms expiring in 2022.
- Voting Results - Directors: Paul A. Mieyal received 38,056,254 votes "For" and 17,297 "Withheld." Malcolm Persen received 36,940,417 votes "For" and 1,133,134 "Withheld."
- Broker Non-Votes: There were 13,953,583 broker non-votes recorded for the director elections.
- Auditor Ratification: Stockholders ratified the selection of Moody, Famiglietti & Andronico, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2019.
- Voting Results - Auditor: The proposal received 50,923,751 votes "For," 1,094,840 "Against," and 8,543 "Abstain."